Table 2 Spearman's rank correlation coefficients between SHQ scores and other HRQOL measures and clinical variables
From: Validation of the japanese version of the sarcoidosis health questionnaire: A cross-sectional study
SHQ-DF | SHQ-PF | SHQ-EF | SHQ-Total | |
|---|---|---|---|---|
SF-36 | ||||
Physical functioning | 0.54 | 0.66 | 0.49 | 0.60 |
Role-physical | 0.70 | 0.60 | 0.66 | 0.74 |
Bodily pain | 0.68 | 0.68 | 0.53 | 0.68 |
General health perceptions | 0.78 | 0.52 | 0.66 | 0.74 |
Vitality | 0.77 | 0.54 | 0.70 | 0.77 |
Social functioning | 0.75 | 0.49 | 0.74 | 0.77 |
Role-emotional | 0.69 | 0.51 | 0.69 | 0.71 |
Mental health | 0.69 | 0.45 | 0.71 | 0.71 |
SGRQ | ||||
Symptoms | -0.30 | -0.48 | -0.27 | -0.35 |
Activity | -0.53 | -0.71 | -0.49 | -0.59 |
Impact | -0.49 | -0.60 | -0.45 | -0.53 |
Total | -0.55 | -0.74 | -0.51 | -0.61 |
Radiographic stage | - | - | - | - |
ACE | - | - | - | - |
sIL2-R | -0.24 | - | -0.20 | -0.22 |
%FVC | 0.18 | 0.27 | - | 0.18 |
%FEV1 | - | - | - | - |
%DLCO | - | - | - | - |
LVEF | - | - | - | - |
PASP | - | -0.38 | - | - |
MRC | -0.44 | -0.56 | -0.46 | -0.50 |
CES-D | -0.65 | -0.39 | -0.70 | -0.68 |